.After F2G's first effort to receive a new course of antifungal to market was thwarted by the FDA, t...
.Moderna has actually pledged to reduce R&D costs through $1.1 billion through 2027. The choice t...
.Only 4 months after Sanofi bet $80 million in upfront cash on Pivot Therapies' losmapimod, the cour...
.Cancer cells business Oncternal Therapies is folding all its own medical tests and giving up staff,...
.Roche is storing out hopes that its injectable obesity prospect could ultimately demonstrate 25% we...
.Novo Nordisk has actually elevated the cover on a stage 1 trial of its own oral amylin as well as G...
.Merely a couple of short weeks after winning an FDA Fast Track tag for its investigational BTK degr...
.Shortly after a good information reduce for Eli Lilly's efsitora alfa, the Indianapolis-based provi...
.BridgeBio Pharma is slashing its own genetics therapy finances and also pulling back coming from th...
.GSK's attempt to cultivate the very first injection for herpes simplex virus (HSV) has finished in ...